chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information hasbeen received from a reistered nurse concerning a 32 yearold female with codeine allergy who on 10/18/2000 was vaccinated with a dose of the measles virus vaccine live (627545/0624K). On 1/5/01, pt was vaccinated with the measles virus vax. On 1/5/01, the pt stated she might be 6 weeks pregnant. Unspecified medical attention was sought. In follow-up, nurse reported that the pt's last menstrual period was 11/5/00. The pt's pregnancy was confirmed by US. The pt had two previous pregnancies and two previous live births without any birth defects. The pt did not have a history of miscarriage or stillbirth the patient was on vitamins (unspecified) during her pregnancy. On 2/15/01, pt had sinusitis and was placed on therapy with amoxicillin until 2/25/01. On 3/7/01, pt developed respiratory infection and was treated with azithromycin IV and Phenergan. On 7/8/01, pt went into preterm labor (37 week gestation). Pt was given terbutaline and nifedipine. On 8/15/01, pt delivered a normal 9 lb 5 oz male. The baby did not have any congenital anomalies. The infant did have reflux. Upon internal review, preterm labor was determined to be an other important medical event. No further info is available.
My birthfather had an adverse reaction after he got his 1st Moderna COVID vaccine.  He lives alone and was doing well with some underlying conditions. The day of the shot was fine.  The next AM, he had vision changes and sudden numbness in his R arm/leg and fell after getting up.  ?The numbness went away pretty quickly, but the visual changes remained.  He refused to go to the ER/Dr.  The next week and a half, he was weak, tired, and couldn?t think as clearly.  ?He was brought to the ER? on Wed, 3/3/21 at Hospital.  He was found to have a low oxygen level, possible a-fib, fluid retention, emphysema, and aortic stenosis, in addition to his other health issues.  ?The Dr said his symptoms the day after the vaccine were a mini-stroke..  He was released from the hospital on Friday, 3/5/21.  On Saturday, Hospice came to see him, since nothing can be done for his medical conditions; however, they decided not to sign him up yet, since he I was told they didn't feel he needed to, at this time.  One of my sisters is staying with him during the day until he builds his strength back up.  Do you think his Mini stroke and health changes had anything to do with the vaccine? He will not be getting the second COVID shot.   ?We?re all caught between a rock and a hard place as far as what to do, esp for older folks.
6/3 64y.o. male with hyperlipidemia who presents with a chief complaint of abdominal distention.
redness; started with a rash from her neck down to her hips, both sides/she is still with this rash; Felling dizzy; Stated she cannot walk to her work.; bad pain all over her body; Headache; pain at the injection site; This case was reported by a pharmacist via call center representative and described the occurrence of erythema in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included paracetamol (Tylenol) for injection site pain, headache, general body pain and dizzy.   On 11th August 2020, the patient received the 1st dose of Shingrix. In August 2020, the patient started Tylenol at an unknown dose and frequency. On 12th August 2020, 1 days after receiving Shingrix, the patient experienced dizziness, unable to walk, general body pain, headache and injection site pain. On 14th August 2020, the patient experienced erythema and rash. The action taken with Tylenol was unknown. On an unknown date, the outcome of the erythema and rash were not recovered/not resolved and the outcome of the dizziness, unable to walk, general body pain, headache and injection site pain were recovered/resolved.   It was unknown if the reporter considered the erythema, rash, dizziness, unable to walk, general body pain, headache and injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient received 1st dose of Shingrix and she experienced pain at the injection site, headache, bad pain all over her body, felling dizzy.  The patient could not walk to her work. The patient  was under Tylenol for this.  On Friday 14th August 2020, the patient felt a little relief of all of the symptoms, she also mentioned that they were over. But on same day afternoon started with a rash from her neck down to her hips, both sides, redness, it does not itch , it was not painful but she was still with this rash. The reporter consented to follow up.  No further details were reported.
The morning following my vaccination, I noticed visible blood in my urine. By the third day after vaccination, the color of my urine was dark red (red wine color) when I first urinated in the morning. The color of my urine had returned to normal by the following Saturday (1/1/2022). My urine also became noticeably frothier after my vaccination and has remained so (as of 1/4/2022). I sought treatment from both my primary care doctor and nephrologist. They both did a urinalysis and bloodwork.
Inability to hold head up, uncoordinated gross motor skills, was not able to reach for objects accurately as previous to vaccination, blank staring, symptoms lasted three weeks, no fever or rashes noted.
reaction vs. septic shcock oncologist worried about delayed anaphylactic reaction. on keytruda. never on chemotherapy.
Post vax, the pt developed a localized reaction with edema, pain, and erythema lasting 3 days. Complaint of headache for 3 days. Treated with Tylenol.
LEFT BELLS PALSY ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/17/2022 &  12/3/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Developed swelling of leg at site of injection, non-tender, no evidence of infection, no abscess (L) leg.
High pitched cry for 12 hours following vaccine administration. Temperature 100 degrees quickly resolved with infant Motrin gets. No local erythema by day #2.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 26-APR-2018, the patient was vaccinated with an improperly stored dose of PEDVAXHIB, lot # N022167, expiration date: 08-FEB-2020 (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 47 to 77 degrees Fahrenheit for 5 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1806USA001505: US-009507513-1806USA009026: US-009507513-1806USA009027: US-009507513-1806USA009029: US-009507513-1806USA009030: US-009507513-1806USA009031: US-009507513-1806USA009032: US-009507513-1806USA009033: US-009507513-1806USA009034: US-009507513-1806USA009035: US-009507513-1806USA009036: US-009507513-1806USA009037: US-009507513-1806USA009038: US-009507513-1806USA009039: US-009507513-1806USA009040: US-009507513-1806USA009041: US-009507513-1806USA009042: US-009507513-1806USA009043: US-009507513-1806USA009044: US-009507513-1806USA009045: US-009507513-1806USA009046: US-009507513-1806USA009047: US-009507513-1806USA009048: US-009507513-1806USA009049: US-009507513-1806USA009050: US-009507513-1806USA009051: US-009507513-1806USA009052: US-009507513-1806USA009053: US-009507513-1806USA009054: US-009507513-1806USA009055: US-009507513-1806USA009056.
12/16/03 pt c/o L arm sore when going to bed-L arm swollen and slightly red. Tonight (12/17/03) L arm more swollen and bright red-1/2 way to elbow. No fever. Arm is sore. Ibuprofen for soreness. Cold compresses.
pt reported itchy throat, tingling, numbness radiating to neck and upper lip and left upper extremity.  Reported redness, swelling that radiated down left arm, dizziness, and weakness to left upper extremity.  Pt reported taking ibuprofen once symptoms presented. Reported to clinic 48 hours after initial vaccine administration, with decreased local reaction symptoms.  Advised pt to seek urgent or emergent medical care if symptoms increased.
Patient seen in the ED on 7/1 for abdominal pain, along with fever and cough. While in the ED, he tested PCR positive for COVID-19. Patient was admitted from 7/1-7/7 for sepsis and choledocholithiasis. This meets criteria for vaccine breakthrough case review.
10 minutes after receiving vaccine pt reports "lump in throat" having difficulty swallowing and trouble taking deep breathes. This RN to car immediately, pulse 70, BP not assessed at this time. Monitored for additional 10 minutes pt reports unable to swallow. EMS notified, arrived 20 minutes (1912)post vaccine administration. Pt reports feeling better and like she can swallow but still lump in her throat. Monitored/assessed by EMS. Pt feels comfortable going home. Pt's son with her and able to drive. Pt reports feeling close to baseline. Pt discharged home and event ended.
Light fewer and in case of that (I guess) a strong migraine attack with vomit. In case of pain relief 200mg ibuprofen has been taken.
after patient received dose, he said, that he had actually gotten the flu shot the month prior. monitored pt for 15 minutes, no adverse effects. checked STC/ONE no record of any other flu shot since 2016. possibly had 2 flu shots.
tingly numb lips; tingly numb lips; headache; difficulty swallowing; Whole head later got tingly; High blood pressure and heart rate; High blood pressure and heart rate; This is a spontaneous report from a contactable consumer (Patient). A 52-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6207, Expiry date was not reported), via an unspecified route of administration, administered in Arm Left on 15Mar2021 at 16:00 (at the age of 52-years-old) as single dose for COVID-19 immunization. The Patient was not pregnant at the time of vaccination. The Patient Medical history included skin cancer removal from an unknown date and unknown if ongoing. The patient's concomitant (two weeks prior vaccination) medications antibiotic (4 days) due to skin cancer removal. Patient not diagnosed with covid-19 prior to vaccination. The Patient had no known allergies. Patient received other medications in two weeks 4 days of antibiotic due to skin cancer removal. Patient was not received any other vaccine four weeks prior vaccination. On 15Mar2021 16:45, the patient experienced with tingly numb lips then headache, difficulty swallowing, Whole head later got tingly, High blood pressure and heart rate. Went to urgent care they wanted her to go to ER. Since vaccination patient not tested for covid-19. Event resulted to visit Emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Outcome of the events was reported as recovering.   No follow-up attempts are Possible. No further information is expected.
Severe erythema, pain, and swelling in deltoid at site of Pneumovax, starting several hours after injection.  Resolved over 5 days with per mouth Cefzil, Benadryl, ice.
Patient developed Guillain-Barre syndrome  Initial exam with symmetric leg weakness and areflexia. MRI with lumbosacral nerve root enhancement. LP with albuminocytologic dissociation.  Treated with IVIG and brief course of plasmapheresis.  Currently improving but still hospitalized  Patient is a 72-year-old with history of bladder cancer, COPD, low back pain with radiculopathy, and renal insufficiency admitted 10/4/2021.  His presenting symptoms were combination of leg weakness and numbness.  Symptoms started after 9/30 and 10/1 when he was putting together dog kennel.  On 10/2 he began to have acute on chronic back pain and by 10/3 he had some weakness but able ambulate without difficulty.  On the morning of 10/4 he was unable to get up from bed.  He started develop some weakness in his hands.  Symptoms are associated with some numbness of the legs which is progressed to his fingertips.  Recent C. difficile infection for the last 3 days and has been on some vancomycin he stopped vancomycin thinking it was associated with his weakness.  Patient thinks his symptoms have gotten even worse since yesterday.  Now he is having more difficulties lifting his arms.  He thinks his left arm is worse than his right arm.  Legs seem to be about the same.  Covid vaccine was around few months ago.  No other recent vaccinations. Patient developed respiratory compromise and needed close monitoring though ultimately did not require intubation. Patient remains hospitalized and will need post-hospital rehab stay. Prognosis is indeterminate.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 04Oct2023 at 11:00 as dose 1, single (Lot number: HG4677) at the age of 73 years, in left arm for covid-19 immunisation; for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid taken from  10Oct2023 to 14Oct2023. The information on the batch/lot number for bnt162b2 omi xbb.1.5  has been requested and will be submitted if and when received.
Severe shaking and tremors - it started with the hands then went through the whole body. After seeing my MD, I was given 2 steroid shots and prescribed Prednisone (20mg) and Hydroxyzine (25mg). The shaking and tremors continue to this day.
I was diagnosed with Lichen Planus, a autoimmune related skin disorder that I never had before.
sick; Initial information received on 22-Jan-2023 regarding an unsolicited valid non-serious case received from a consumer via social media.  This case involves a patient of unknown age and gender who got sick after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant disease or risk factor and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, route, formulation, batch number and expiry date: unknown) in unknown administration site for prophylactic vaccination (immunization).  On an unknown date, the patient fell sick (illness) (latency: unknown) following the administration of influenza vaccine.  It is unknown if there were lab data/results available.  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event.   At time of reporting, the outcome was Unknown for the event.
Information has been received from a lawyer and a consumer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medications were not provided. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX (lot# and route not provided) to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 25-JAN-2013, a nurse administered the ZOSTAVAX vaccine to the patient. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related injuries. On or about 08-JAN-2017, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX vaccine. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
Pt reports receiving 2 doses of Moderna COVID-19 Vaccine, however only 1 dose on 5/1/2021 documented in system. Pt reported 2nd dose was in May. On/around 12/15, she developed SOB, cough, and congestion. Presented to hospital on 12/22. Tested positive for acute COVID-19 on 12/23/2021
No adverse effects noted; a patient received improperly stored VARIVAX. DILUENT (S015772 2/15/2022) was stored properly; This spontaneous report was received from a medical assistant referring to a female patient of unknown age. Information about medical history, concurrent conditions, drug reactions/allergies and concomitant therapies was not provided.   On 01-OCT-2019, the patient vaccinated with improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # S011951, expiration date reported as 16-APR-2019, but upon internal validation established as 16-APR-2021; vaccine dosage detail not reported) for prophylaxis reconstituted with properly stored sterile diluent (lot # S015772, expiration date 15-FEB-2022) (product storage error). The storage temperature of varicella virus vaccine live (Oka/Merck) (VARIVAX) was -12.3 Celsius degrees for 6.05 hours. There was no previous temperature excursion. No adverse effects noted. No product quality complaints (PQC). Data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1910USA006992: US-009507513-1910USA007211: US-009507513-1910USA007203: US-009507513-1910USA007200: US-009507513-1910USA007348: US-009507513-1910USA007375:
Bad reaction; This case was reported by a consumer via call center representative and described the occurrence of adverse reaction in a child female patient who received DTPa (DTPa vaccine) for an unknown indication.   On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to DTPa vaccine.  Additional details were provided as follows: The reporter was the patient's mother. The age at vaccination was not reported. The patient's mother reported that, the patient previously had bad reaction to the immunization, but did not stated to which vaccine, patient had a bad reaction. The reporter was trying to find out if the Whooping cough vaccine was available as an individual vaccine. The reporter needed to get updates on dtap and meningococcal vaccine. No additional information was provided.
This is a spontaneous report received from contactable consumer or other non-HCP (patient). Other case identifier: 2022SA006650. A 60-year-old female patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient developed a rash (spread all over her body) and atopic dermatitis (after the COVID-19 shot, a flare broke-out on hips, stomach and chest), with outcome of unknown. Therapeutic measures were taken as a result of rash and atopic dermatitis. The batch/lot number for BNT162B2 not provided and will be requested during follow-up.
9 cm area of firm, slightly warm, mildly erythematous soft tissue swelling over right deltoid region first noticed by father on 2/?/02 at approximately 10 a.m. when assisting child changing clothes. No complaint of discomfort from child. Full ROM of right arm shoulder without pain. No fever or illness Symptoms diagnosed localized vaccine reaction, R/O infection Rx Keflex 25 mg 1.5 tsp R, Ax Zd. Recheck planned 2/10/03.
J18.9 - Pneumonia, unspecified organism R65.10 - Systemic inflammatory response syndrome (sirs) of non-infectious origin without acute organ dysfunction
both daughters are experiencing the same thing/pain in arms; couldn't move her arm; This is a spontaneous report from a contactable consumer (patient's mother) from a Pfizer sponsored program. The consumer reported similar events for three patients. This is the third of three reports.   A female patient of an unspecified age received bnt162b2 (Pfizer BioNTech Covid 19 vaccine), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot Number: Not Provided) at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Reporter was calling on behalf of her daughter that had the first dose of the COVID 19 vaccine and her daughter was experiencing pain in arms. Reporter stated she had three daughters and two received the COVID 19 vaccine and both were experiencing the same thing. Reporter stated the daughter (patient) yesterday had no pain, only at night she was complaining about having pain and then woke up this morning and the daughter said she couldn't move her arm she was in severe pain. Reporter stated the daughter did not work today but yesterday she worked and last night decided she would not be going because she has to use her arms at work and it was really difficult for her. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021423442 Same reporter/drug, different patients, similar AEs;US-PFIZER INC-2021425734 Same reporter/drug, different patients, similar AEs
Classic flu-like symptoms - headache, body ache, sore throat, dry cough, low grade fever, fatigue
no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to a 6-month-old patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 07-JAN-2021, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) lot # T013204, expiration date was not provided, but upon internal validation process it was established as 03-DEC-2021 (dose, route of administration and anatomical location were not provided) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 47.01 Fahrenheit (F) for 1 minute 30 seconds. Data logger was involved. There were no previous excursions reported. No additional adverse events were reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2102USA003923: US-009507513-2102USA004059: US-009507513-2102USA004059:
17 yo girl with 4-extremity paralysis and tingling sensation on 10/9/15 the day after receiving above vaccines. 911 called from school. Given SOLU-MEDROL, BENADRYL en route to ER. By the time she arrived at ER after NS bolus, she started to move extremities again.
stiffness in arm, bruised, hot;to MD rx compresses to ATB;recovered x 3 days-to pre-immun status;